exhibit 10. 14 master agreement by and between mpi research, inc. ( hereinafter referred to as mpi ) mattawan, michigan and phage biotechnology corporation ( hereinafter referred to as the sponsor ) tustin, california notice : this document contains company confidential and / or proprietary information belonging to mpi and the sponsor. none of the information may be copied, transmitted or communicated in whole or in part to any third party without the written consent of the parties. i. definitions • the master agreement outlines the general terms of the contract between mpi and the sponsor. • the services agreement details the specific terms for each study of the contract between mpi and the sponsor. this includes the billing schedule for the study. • the protocol is a detailed description of the study as required in the applicable good laboratory practices regulations. ii. work to be done and costs mpi agrees to carry out the study ( ies ) for the sponsor according to the written protocol ( s ). the protocol ( s ) are attached as exhibit a to the services agreement addendum and are incorporated herein by reference. for performing this ( these ) study ( ies ), mpi shall receive the sums indicated on the services agreement addendum for each study performed for the sponsor. in the performance of this agreement, mpi shall comply with all applicable u. s. laws, ordinances, rules and regulations, whether federal, state or local. mpi affirms that it is registered with the usda as a laboratory conducting research on laboratory animals and that all conditions of animal care and testing will conform to the animal welfare act. mpi is an aaalac accredited facility and mpi warrants that, to the best of its knowledge, it is currently in compliance with and that it will, to the best of its ability, remain in compliance with and fulfill all governmental requirements regarding applicable good laboratory practices. master agreement phage biotechnology corporation page 2 iii. confidentiality mpi agrees that it shall not disclose to any third party any information concerning the study ( ies ) or any data derived therefrom that it obtains during the course of its performance of this agreement without the prior written consent of the sponsor. appropriately authorized regulatory officials will be provided access to study information upon request, and mpi will notify the sponsor immediately upon the regulatory official ’ s request. this obligation shall survive the cancellation or the termination of this agreement. mpi agrees